These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2916768

  • 1. Effects of glycosaminoglycans and protamine chloridrate on platelet aggregation induced by collagen and thrombin.
    Luzzatto G, Paolini R, Stevanato F, Simioni P, Cella G.
    Angiology; 1989 Mar; 40(3):170-4. PubMed ID: 2916768
    [Abstract] [Full Text] [Related]

  • 2. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
    Maaroufi RM, Giordano P, Triadou P, Tapon-Bretaudière J, Dautzenberg MD, Fischer AM.
    Thromb Res; 2007 Mar; 120(4):615-21. PubMed ID: 17222891
    [Abstract] [Full Text] [Related]

  • 3. Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregation.
    Klein K, Sinzinger H, Silberbauer K, Stachelberger H, Leithner C.
    Artery; 1980 Mar; 8(5):410-5. PubMed ID: 6783013
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA.
    Nouv Rev Fr Hematol (1978); 1988 Mar; 30(3):155-60. PubMed ID: 2971155
    [Abstract] [Full Text] [Related]

  • 5. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G, Scattolo N, Luzzatto G, Stevanato F, Vio C, Girolami A.
    J Med; 1986 Mar; 17(5-6):331-46. PubMed ID: 2953835
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA.
    Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
    [Abstract] [Full Text] [Related]

  • 9. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans.
    Cosmi B, Cini M, Legnani C, Pancani C, Calanni F, Coccheri S.
    Thromb Res; 2003 Mar 15; 109(5-6):333-9. PubMed ID: 12818259
    [Abstract] [Full Text] [Related]

  • 10. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K, Kitazato KT, Sasaki E, Minamiguchi K, Nagase H.
    Thromb Res; 2003 Mar 15; 112(1-2):83-91. PubMed ID: 15013278
    [Abstract] [Full Text] [Related]

  • 11. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
    Cofrancesco E, Colombi M, Gianese F, Cortellaro M.
    Thromb Res; 1990 Feb 01; 57(3):405-14. PubMed ID: 2138364
    [Abstract] [Full Text] [Related]

  • 12. Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
    Hoppensteadt DA, Walenga JM, Fareed J.
    Semin Thromb Hemost; 1991 Feb 01; 17 Suppl 1():60-4. PubMed ID: 2068572
    [Abstract] [Full Text] [Related]

  • 13. Proteoglycan obtained from bovine aorta suppress thrombin-induced platelet aggregation.
    Nakashima Y, Matsushima T, Sadayasu T, Takahara K, Segawa J, Kuroiwa A.
    Artery; 1992 Feb 01; 19(5):256-70. PubMed ID: 1444838
    [Abstract] [Full Text] [Related]

  • 14. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.
    Rajtar G, Marchi E, de Gaetano G, Cerletti C.
    Biochem Pharmacol; 1993 Sep 01; 46(5):958-60. PubMed ID: 8373448
    [Abstract] [Full Text] [Related]

  • 15. Effect of heparin and related glycosaminoglycans (GAGs) on thrombin-induced platelet aggregation and release.
    Cofrancesco E, Colombi M, Manfreda M, Pogliani EM.
    Haematologica; 1988 Sep 01; 73(6):471-5. PubMed ID: 3148509
    [No Abstract] [Full Text] [Related]

  • 16. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.
    Møller AV, Jørgensen SP, Chen JW, Larnkjaer A, Ledet T, Flyvbjerg A, Frystyk J.
    Eur J Endocrinol; 2006 Aug 01; 155(2):297-305. PubMed ID: 16868144
    [Abstract] [Full Text] [Related]

  • 17. Normal and low molecular weight heparins: interaction with human platelets.
    Fabris F, Fussi F, Casonato A, Visentin L, Randi M, Smith MR, Girolami A.
    Eur J Clin Invest; 1983 Apr 01; 13(2):135-9. PubMed ID: 6223824
    [Abstract] [Full Text] [Related]

  • 18. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A, Breiter N, Ogawa T, Asai F, Koike H.
    Thromb Haemost; 1996 Nov 01; 76(5):786-90. PubMed ID: 8950791
    [Abstract] [Full Text] [Related]

  • 19. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
    Messmore HL, Griffin B, Koza M, Seghatchian J, Fareed J, Coyne E.
    Semin Thromb Hemost; 1991 Nov 01; 17 Suppl 1():57-9. PubMed ID: 1712512
    [Abstract] [Full Text] [Related]

  • 20. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.
    Petzelbauer E, Seiffert D, Beckmann R, Pusch B, Geiger M, Binder BR.
    Thromb Res; 1992 Jun 01; 66(5):559-67. PubMed ID: 1381850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.